Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Multiple Sclerosis Detected by Analysis of Exhaled Breath

By LabMedica International staff writers
Posted on 23 Aug 2012
A sensor array has been developed that can diagnose multiple sclerosis (MS) from exhaled breath.

Scientists identified volatile organic compounds from exhaled breath that can be associated with MS. More...
Based on these findings they developed a sensor array that can diagnose MS by analyzing the compounds that appear in the breath of MS patients. The cross-reactive array of polycyclic aromatic hydrocarbons and single wall carbon-nanotube bilayers were designed for the detection of volatile organic compounds (hexanal and 5-methyl-undecane) that identify the presence of disease in the exhaled breath of patients with MS.

Using the sensors, the scientists carried out a proof-of-concept clinical study on 34 MS patients and 17 healthy volunteers and found that the developed sensors are just as accurate as a lumbar puncture but without the pain or the risk of side effects. Results obtained from the study showed that the sensors could discriminate between MS and healthy states from exhaled breath samples with 85.3% sensitivity, 70.6% specificity, and 80.4% accuracy.

Initiator and coordinator of the study, Prof. Hossam Haick at the department of chemical engineering and Russell Berrie Nanotechnology Institute, Technion–Israel Institute of Technology (Haifa, Israel) and colleagues report that doctors currently diagnose MS according to clinical symptoms, which include muscle spasms, numbness, coordination problems, and slurred speech. Confirmation of the diagnosis is made by either magnetic resonance imaging (MRI), which is costly, or lumbar puncture, which is invasive and can be painful with unpleasant side effects.


The study was published in the journal ACS Chemical Neuroscience in 2012.

Related Links:

Technion–Israel Institute of Technology




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gastrointestinal Panel
Xpert® GI Panel
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.